title: Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.
authors.forename: Laurence
authors.initials: L
authors.lastname: Ollier
authors.forename: Nathalie
authors.initials: N
authors.lastname: Tieulie
authors.forename: Frédérick
authors.initials: F
authors.lastname: Sanderson
authors.forename: Philippe
authors.initials: P
authors.lastname: Heudier
authors.forename: Valérie
authors.initials: V
authors.lastname: Giordanengo
authors.forename: Jean-Gabriel
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Nicand
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002908:Chronic Disease; D016751:Hepatitis E / Q000175:diagnosis* / Q000821:virology; D006801:Humans; D016867:Immunocompromised Host; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000276:immunology*; D008297:Male; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab